| Literature DB >> 18582360 |
Panita Gosi1, Srisin Khusmith, Thareerat Khalambaheti, David E Lanar, Kurt E Schaecher, Mark M Fukuda, Scott R Miller.
Abstract
BACKGROUND: The Duffy-binding protein II of Plasmodium vivax (PvDBPII) has been considered as an attractive target for vaccine-mediated immunity despite a possible highly polymorphic nature. Among seven PvDBP domains, domain II has been shown to exhibit a high rate of nonsynonymous polymorphism, which has been suggested to be a potential immune (antibody binding) evasion mechanism. This study aimed to determine the extent of genetic polymorphisms and positive natural selection at domain II of the PvDBP gene among a sampling of Thai P. vivax isolates.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18582360 PMCID: PMC2443374 DOI: 10.1186/1475-2875-7-112
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
PvDBPII sequences deposited in GenBank used in the study
| species | locality | GenBank accession number |
| Papua New Guinea | ||
| Colombia | ||
| Korea | ||
| India | ||
| Brazil | ||
| Vietnam | ||
| Indonesia | ||
| Sal I |
Figure 1Schematic diagram of PvDBPII gene showing the location of the primers.
Amino acid changes found in PvDBPII gene among 30 Thai isolates, comparing to DBP Sal I sequence.
| Position of the amino acid | ▼ | ▽ | ▼ | ||||||||||||
| 268 | 276 | 281 | 306 | 308 | 333 | 351 | 367 | 371 | 375 | 378 | 384 | 385 | 386 | 390 | |
| SalI | CGT | AAC | GTT | TTT | AGG | CTT | AGT | ATC | AAA | AAT | CGC | GAT | GAA | AAG | CGT |
| Thai | AGT | AAT | GTA | TTG | AGT | TTT | TGT | ACC | GAA | GAT | CGT | GGT | AAA | AAT/CAG | CAT |
| SalI | R | N | V | F | R | L | S | I | K | N | R | D | E | K | R |
| Thai | S | N | V | L | S | F | C | T | E | D | R | G | K | N/Q | H |
| a | (1/30) | (1/30) | (1/30) | (2/30) | (8/30) | (14/30) | (1/30) | (2/30) | (6/30) | (7/30) | (30/30) | (23/30) | (14/30) | (13/30) | (17/30) |
| b | 3 | 3 | 3 | 6 | 26 | 46 | 3 | 6 | 20 | 23 | 100 | 76 | 46 | 43 | 56 |
| Position of the amino acid | ▼ | ▼ | ▼ | ||||||||||||
| 398 | 404 | 417 | 419 | 424 | 433 | 436 | 437 | 447 | 464 | 475 | 486 | 503 | 507 | 513 | |
| Sal I | TCT | ACA | AAT | ATA | TTA | CAG | AGA | TGG | TCA | ATC | CCA | CAA | ATA | AAC | ACG |
| Thai | ACT | AGA | AAA | ATG | ATA | AAG | ACA | CGG | TCC | ATA | GCA | GAA | AAA | CAC | AAG |
| Sal I | S | T | N | I | L | Q | R | W | S | I | P | Q | I | N | T |
| Thai | T | R | K | M | I | K | T | R | S | I | A | E | K | H | K |
| a | (3/30) | (3/30) | (11/30) | (1/30) | (26/30) | (1/30) | (1/30) | (19/30) | (1/30) | (1/30) | (3/30) | (2/30) | (17/30) | (1/30) | (1/30) |
| b | 10 | 10 | 36 | 3 | 86 | 3 | 3 | 63 | 3 | 3 | 10 | 6 | 56 | 3 | 3 |
a Showing the detection frequency of each amino acids variant on PvDBPII protein among 30 Thai isolates.
b Percentage of detection frequency calculated from value in panel "a".
▼ High prevalence (>50%) of variant amino acids.
▽ Dimorphic mutation (changed into two amino acid-types)
PvDBPII haplotypes observed among 30 Thai isolates.
| Haplotype name | Amino acid haplotype* | No. of isolate observed (%) |
| TA 1 | RFRFSIKDGKNHSTKIIQRRPQKNT | 2(6.6) |
| TA 2 | RFSFSIKDGKNHSTKIIQRRPQKNT | 1(3.3) |
| TA3 | RFSFSIKDGKKHSTKIIQRRPQKNT | 1(3.3) |
| TA 4 | RFRLSIKDGKNHSTKIIQRRPQKNT | 1(3.3) |
| TA 5 | RFRFSIENGKNRSTNIIQRRPQINT | 2(6.6) |
| TA6 | RFRFSIENGKNRSTKIIQRRPQINT | 1(3.3) |
| TA 7 | RFSFSIKDGKNHSTNIIQRRPQINT | 1(3.3) |
| TA 8 | RFRLSIENGEKHSTKIIQRRPQKNT | 1(3.3) |
| TA 9 | RFRLSIENGEQRSTKIIQRRPQKNT | 1(3.3) |
| TA 10 | RFRLSIENGEKRSTKMIQRRPQINT | 1(3.3) |
| TA 11 | RLSLLSIKNGKNHTRNIIQRWPQINT | 2(6.6) |
| TA 12 | SFSLSIKNGKNHTRNIQRWPEINT | 1(3.3) |
| TA 13 | RFRLSTKNGEKHSTNIIQRWPQKHT | 1(3.3) |
| TA 14 | RFRLSTKNGEKHSTNIIQRWPQKHT | 1(3.3) |
| TA 15 | RFSLSIKNGEKRSTNIIQRWPQKNT | 1(3.3) |
| TA 16 | RFRLSIKNGEKRSTNIIQRWPQINT | 1(3.3) |
| TA 17 | RFRFSIKNDEKRSTNIIQRRAQKNT | 3(10) |
| TA 18 | RFRLSIKNDEKRSTNIIQRRPQKNT | 1(3.3) |
| TA19 | RFRFSIKNDKKRSTNIIQRRPQKNT | 1(3.3) |
| TA 20 | RFRLSIKNDKKRSTKIIKTRPQINT | 1(3.3) |
| TA 21 | RFRLSIKNDKKRSTNIIQRWPQINT | 1(3.3) |
| TA 22 | RFSFSIKDGKNHSTNILQRRPQKNT | 1(3.3) |
| TA23 | RFRLSIKNGEKHSTNILQRWPQKNK | 1(3.3) |
| TA 24 | RFRLCIKNGEKHSTNILQRWPEINT | 1(3.3) |
| TA 25 | RFRLSIKNGEKHSTNILQRWPQINT | 1(3.3) |
* Amino acid residues included in the haplotypes are as follows: 268, 306, 308, 333, 351, 367, 371, 375, 384, 385, 386, 390, 398, 404, 417, 419, 424, 433, 436, 437, 475, 486, 503, 507, 513.
Figure 2Neighbour-Joining tree of PvDBPII amino acid sequence of 25 variants observed among 30 Thai isolates. The PvDBPII haplotype for each variant could be seen in Table 3.
Figure 3Phylogenetic tree of PvDBPII obtaining from Thai P. vivax isolates and other isolates from different geographical malaria endemic areas, i.e. PNG (Papua New Guinea), India, COL (Colombia), Korea, Bangladesh, Brazil, Indonesia, Vietnam, and Sal I. Numbers at nodes indicate percentage support of 1000 bootstrap replicates (bootstrap support values below 10 are not presented).
Frequencies of the most common variant amino acids in PvDBPII, comparing to Sal I sequence (accession number M37519)
| # | R308S | D384G | K386N | K386Q | N417K | L424I | W437R | S447K | I503K |
| Thai | 26 | 76 | 40 | 3 | 36 | 86 | 63 | 0 | 56 |
| COL* | 0 | 59 | 23 | 0 | 47 | 47 | 18 | 0 | 12 |
| PNG* | 67 | 66 | 8 | 11 | 23 | 34 | 26 | 59 | 29 |
| Brazil* | 12.5 | 85 | 12.5 | 0 | 27.5 | 32.5 | 27.5 | 0 | 55 |
* The frequencies of the common variant amino acid data were referable according to Sousa et al. 2006.
# The first letter represented the amino acid in that position in Sal I sequences, and the other letter represents the substituted amino acid.
COL: Colombia, PNG: Papua New Guinea